SHARMIN NURANI: Open Payments
NPI 1972807386 · SACATON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,503 in 182 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $238 · 2025 $5,503
Food & beverage: $5,404Education: $99
| Company | Payments | Amount |
|---|---|---|
| Noctrix Health, Inc. | 1 | $2,401 |
| Teva Pharmaceuticals USA, Inc. | 16 | $339 |
| Biogen, Inc. | 27 | $337 |
| Lilly USA, LLC | 7 | $230 |
| ARGENX US, INC. | 9 | $228 |
| Genentech USA, Inc. | 9 | $226 |
| Celgene Corporation | 19 | $218 |
| UCB, Inc. | 19 | $209 |
| ABBVIE INC. | 14 | $194 |
| Amneal Pharmaceuticals LLC | 13 | $190 |
Products named: NIDRA, KISUNLA, Ocrevus Zunovo, ZEPOSIA, VUMERITY, CREXONT, Leqembi, AUSTEDO XR.
Industry payments across AZ — which companies pay providers there.
